Using generative AI to help diagnose complications of rheumatoid arthritis.
Impact of Generative Artificial Intelligence on Diagnosing Rheumatoid Arthritis Complications
This project will test whether generative AI prediction reports can help doctors find complications and other health problems in people with rheumatoid arthritis.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Sex | All |
| Sponsor | Guang'anmen Hospital of China Academy of Chinese Medical Sciences Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT07301892 on ClinicalTrials.gov |
What this trial studies
This observational project uses patients' electronic health records and a generative AI model to generate prediction reports about RA complications and co-existing diseases. In a retrospective phase, investigators will quantify physician adoption of AI predictions by reviewing past inpatient records. In a prospective phase, clinicians will receive AI prediction reports alongside usual clinical information to see whether it is feasible to use those reports to make more complete diagnoses, including complex, uncommon, or rare conditions. The work is conducted at Guang'anmen Hospital in Beijing and focuses on real-world RA inpatients admitted during the study period.
Who should consider this trial
Good fit: Ideal participants are inpatients with an initial diagnosis of rheumatoid arthritis admitted to Guang'anmen Hospital during the study period.
Not a fit: People who are later confirmed not to have rheumatoid arthritis, outpatients, or patients without usable electronic health records are unlikely to receive benefit from this study.
Why it matters
Potential benefit: If successful, this approach could help clinicians detect RA complications earlier and more completely, potentially improving patient management and outcomes.
How similar studies have performed: Early research on AI and large language models for diagnostic support has shown promising retrospective results, but prospective validation for routine clinical use is still limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with an initial diagnosis of rheumatoid arthritis (RA). * All real-world RA inpatients admitted to our department. * Admission occurring within the real-world data study period. Exclusion Criteria: * Patients subsequently confirmed not to have RA during the study.
Where this trial is running
Beijing, Beijing Municipality
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Quan Jiang Guang'anmen Hospital, China Academy of Chinese Medical Science
- Email: doctorjq@126.com
- Phone: 010-88001942
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.